Announcement of the State Food and Drug Administration on the revision of the drug inserts of 14 varieties including paracetamol and Mami Oral Solution (No. 57 of 2021)

In order to further protect the safety of public medication, the National Medical Products Administration has decided to treat paracetamol and acetaminophen, acetaminophen and acetaminophen syrup, pediatric paracetamol granules, paracetamol and pseudoephedrine chewable tablets, pediatric compound paracetamol tablets, and pediatric ammonia Kahuangmin Granules, Aminojinjinmin Granules, Aminocayumin Solution, Children's Compound Paracetamol and Renin Tablets, Aminocahuangmin Oral Solution, Paracetamol and Pseudoephedrine Dispersible Tablets (Ⅲ), Pediatric Paracetamol and Namin Tablets, Pediatric The drug inserts of 14 varieties including Paracetamol Huang Namin Tablets and Pediatric Paracetamol Huang Namin Granules were revised

1.

If the revised content involves the label of a drug, it shall be revised together; the instructions and other content of the label shall be consistent with the original approved content

2.

3.

4.

5.

Hereby announce

Attachment: Requirements for revision of drug inserts for 14 varieties including paracetamol Asami oral solution

State Food and Drug Administration

April 21, 2021